Skip to main content
. 2020 Mar 12;7(9):1902971. doi: 10.1002/advs.201902971

Table 2.

Comparison of type I and type II GSCs

Type I Type II
CD133 marker +
Transcriptional profile a) Proneural Mesenchymal
Molecular signature Fetal NSC Adult NSC
Growth Gliomaspheres Semi‐adherent, invasive
Tumorigenic potential High Low
a)

According to ref. [6] and data from ref. [5].